| Ident. | Authors (with country if any) | Title |
|---|
| 000268 (2019) |
Emiliano Matos-Perdomo [Espagne] ; Félix Machín [Espagne] | Nucleolar and Ribosomal DNA Structure under Stress: Yeast Lessons for Aging and Cancer. |
| 000391 (2019) |
Francesca Chiarini [Italie] ; Camilla Evangelisti [Italie] ; Giovanna Lattanzi [Italie] ; James A. Mccubrey [États-Unis] ; Alberto M. Martelli [Italie] | Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells. |
| 000433 (2018) |
Laura Hulea [Canada] ; Simon-Pierre Gravel [Canada] ; Masahiro Morita [Japon] ; Marie Cargnello [France] ; Oro Uchenunu [Canada] ; Young Kyuen Im [Canada] ; Camille Lehuédé [Canada] ; Eric H. Ma [Canada] ; Matthew Leibovitch [Canada] ; Shannon Mclaughlan [Canada] ; Marie-José Blouin [Canada] ; Maxime Parisotto [Canada] ; Vasilios Papavasiliou [Canada] ; Cynthia Lavoie [Canada] ; Ola Larsson [Suède] ; Michael Ohh [Canada] ; Tiago Ferreira [Canada] ; Celia Greenwood [Canada] ; Gaëlle Bridon [Canada] ; Daina Avizonis [Canada] ; Gerardo Ferbeyre [Canada] ; Peter Siegel [Canada] ; Russell G. Jones [Canada] ; William Muller [Canada] ; Josie Ursini-Siegel [Canada] ; Julie St-Pierre [Canada] ; Michael Pollak [Canada] ; Ivan Topisirovic [Canada] | Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides. |
| 000440 (2018) |
Arash Soltani [Iran] ; Amirhossein Bahreyni [Iran] ; Nadia Boroumand [Iran] ; Mostafa Karimi Roshan [Iran] ; Majid Khazaei [Iran] ; Mikhail Ryzhikov [États-Unis] ; Saman Soleimanpour [Iran] ; Amir Avan [Iran] ; Seyed Mahdi Hassanian [Iran] | Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives. |
| 000617 (2018) |
Alberto M. Martelli [Italie] ; Francesca Buontempo [Italie] ; James A. Mccubrey [États-Unis] | Drug discovery targeting the mTOR pathway. |
| 000662 (2018) |
Jeffrey J. Heard [États-Unis] ; Ivy Phung [États-Unis] ; Mark I. Potes [États-Unis] ; Fuyuhiko Tamanoi [États-Unis, Japon] | An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation. |
| 000665 (2018) |
Chadi Zakaria [Canada] ; Polen Sean [Canada] ; Huy-Dung Hoang [Canada] ; Louis-Phillipe Leroux [Canada] ; Margaret Watson [Canada] ; Samuel Tekeste Workenhe [Canada] ; Jaclyn Hearnden [Canada] ; Dana Pearl [Canada] ; Vinh Tai Truong [Canada] ; Nathaniel Robichaud [Canada] ; Akiko Yanagiya [Canada] ; Soroush Tahmasebi [Canada] ; Seyed Mehdi Jafarnejad [Canada] ; Jian-Jun Jia [Canada] ; Adrian Pelin [Canada] ; Jean-Simon Diallo [Canada] ; Fabrice Le Boeuf [Canada] ; John Cameron Bell [Canada] ; Karen Louise Mossman [Canada] ; Tyson Ernst Graber [Canada] ; Maritza Jaramillo [Canada] ; Nahum Sonenberg [Canada] ; Tommy Alain [Canada] | Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis. |
| 000754 (2017) |
James A. Mccubrey [États-Unis] ; Kvin Lertpiriyapong [États-Unis] ; Linda S. Steelman [États-Unis] ; Steve L. Abrams [États-Unis] ; Lucio Cocco [Italie] ; Stefano Ratti [Italie] ; Alberto M. Martelli [Italie] ; Saverio Candido [Italie] ; Massimo Libra [Italie] ; Giuseppe Montalto [Italie] ; Melchiorre Cervello [Italie] ; Agnieszka Gizak [Pologne] ; Dariusz Rakus [Pologne] | Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. |
| 000812 (2017) |
Karin Hoppe-Seyler [Allemagne] ; Felicitas Bossler [Allemagne] ; Claudia Lohrey [Allemagne] ; Julia Bulkescher [Allemagne] ; Frank Rösl [Allemagne] ; Lars Jansen [Allemagne] ; Arnulf Mayer [Allemagne] ; Peter Vaupel [Allemagne] ; Matthias Dürst [Allemagne] ; Felix Hoppe-Seyler [Allemagne] | Induction of dormancy in hypoxic human papillomavirus-positive cancer cells. |
| 000843 (2017) |
James A. Mccubrey [États-Unis] ; Lucio Cocco [Italie] | GSK-3 signaling in health. |
| 000898 (2017) |
Johan W. De Fijter [Pays-Bas] | Cancer and mTOR Inhibitors in Transplant Recipients. |
| 000918 (2017) |
Yuki Kunisada [Japon] ; Shingo Eikawa [Japon] ; Nahoko Tomonobu [Japon] ; Shohei Domae [Japon] ; Takenori Uehara [Japon] ; Shohei Hori [Japon] ; Yukihiro Furusawa [Japon] ; Koji Hase [Japon] ; Akira Sasaki [Japon] ; Heiichiro Udono [Japon] | Attenuation of CD4+CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug. |
| 000974 (2016) |
Paula Andrea Marin Zapata [Allemagne] ; Carsten Jörn Beese [Allemagne] ; Anja Jünger [Allemagne] ; Giovanni Dalmasso [Allemagne] ; Nathan Ryan Brady [Allemagne, États-Unis] ; Anne Hamacher-Brady [Allemagne, États-Unis] | Time course decomposition of cell heterogeneity in TFEB signaling states reveals homeostatic mechanisms restricting the magnitude and duration of TFEB responses to mTOR activity modulation. |
| 000980 (2016) |
Dixon H. Xu [États-Unis] ; Ziwen Zhu [États-Unis] ; Mark R. Wakefield [États-Unis] ; Huaping Xiao [République populaire de Chine] ; Qian Bai [États-Unis] ; Yujiang Fang [États-Unis] | The role of IL-11 in immunity and cancer. |
| 000A44 (2016) |
Haiyan Cui [République populaire de Chine] ; Shufen Wu [République populaire de Chine] ; Yunfei Shang [République populaire de Chine] ; Zhenjing Li [République populaire de Chine] ; Mianhua Chen [République populaire de Chine] ; Fengjuan Li [République populaire de Chine] ; Changlu Wang [République populaire de Chine] | Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth. |
| 000B72 (2015) |
Andras Perl [États-Unis] | mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. |
| 000B91 (2015) |
Lifang Zhang [République populaire de Chine] ; Jianhong Wu [Australie, République populaire de Chine] ; Ming Tat Ling [Australie] ; Liang Zhao [Australie] ; Kong-Nan Zhao [République populaire de Chine, Australie] | The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. |
| 000C35 (2015) |
Pengda Liu [États-Unis] ; Wenjian Gan [États-Unis] ; Y Rebecca Chin [États-Unis] ; Kohei Ogura [États-Unis] ; Jianping Guo [États-Unis] ; Jinfang Zhang [États-Unis] ; Bin Wang [États-Unis] ; John Blenis [États-Unis] ; Lewis C. Cantley [États-Unis] ; Alex Toker [États-Unis] ; Bing Su [États-Unis] ; Wenyi Wei [États-Unis] | PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex. |
| 000C98 (2015) |
Yi-Hsuan Ho [États-Unis] ; Audrey P. Gasch [États-Unis] | Exploiting the yeast stress-activated signaling network to inform on stress biology and disease signaling. |
| 000D21 (2015) |
Francesca Chiarini [Italie] ; Camilla Evangelisti [Italie] ; James A. Mccubrey [États-Unis] ; Alberto M. Martelli [Italie] | Current treatment strategies for inhibiting mTOR in cancer. |
| 000E32 (2014) |
Pravin Kesarwani [États-Unis] ; Amir A. Al-Khami [États-Unis] ; Gina Scurti [États-Unis] ; Krishnamurthy Thyagarajan [États-Unis] ; Navtej Kaur [États-Unis] ; Shahid Husain [États-Unis] ; Quan Fang [États-Unis] ; Osama S. Naga [États-Unis] ; Patricia Simms [États-Unis] ; Gyda Beeson [États-Unis] ; Christina Voelkel-Johnson [États-Unis] ; Elizabeth Garrett-Mayer [États-Unis] ; Craig C. Beeson [États-Unis] ; Michael I. Nishimura [États-Unis] ; Shikhar Mehrotra [États-Unis] | Promoting thiol expression increases the durability of antitumor T-cell functions. |
